Medtronic and Abbott Launch First Joint Product: MiniMed 780G with Instinct CGM in the U.S.

Medtronic announced its collaboration with Abbott to developMiniMed 780G Insulin Pump+Instinct CGM Officially Launches Commercialization in the United States. MiniMed 780G+Instinct, the first product of the collaboration between Medtronic and Abbott, received FDA approval for market release in September this year.For the treatment of type 1 diabetes.

Expert Evaluation

"Combining Abbott's Instinct sensor with the outstanding algorithm of the MiniMed 780G has created an extremely effective combination. With the MiniMed 780G, my patients' time in target blood glucose range has improved, and now with the integration of the Instinct sensor, the experience is even more seamless. Feedback from the early customer pilot program has been very positive, consistent with what my colleagues and I have observed in the clinic. I am thrilled that the Instinct sensor is now commercially available, allowing more individuals with Type 1 diabetes to access this life-changing technology and improve their daily experience managing this challenging condition."

---Steve Edelman Taking Control of Your Diabetes 501c3

Executive Evaluation

"This milestone marks an important next step in bringing the clinically proven benefits of the MiniMed 780G to more people with diabetes. With this launch, we are expanding a smart insulin delivery ecosystem built on choice, so that everyone can find a solution that fits their life. We exist to make life with diabetes easier and more predictable, giving people with diabetes greater freedom and better health every day. Our goal is to provide confidence and peace of mind so that everyone – including loved ones – can live boldly without compromise."

---Que Dallara   Executive Vice President and President of Medtronic Diabetes Business Group

MiniMed 780G+The approval of Instinct marks the first collaboration between Medtronic and Abbott, two industry giants.Instinct is Abbott's dedicated product for MedtronicMiniMed 780GThe CGM developed and designed isThe world's smallest, thinnest, and most discreet integrated CGM (iCGM), with a wear time of up to 15 days.

According to MedtronicInsTinct compared with Medtronic's most advanced CGM (Simplera Sync), with significant advantages. FirstMean Absolute Relative Error (MARD) become smaller, and the wearing time becomes longer (Simplera Sync can only be worn for 7 days.), in additionInstinct is also smaller andThin (Better protection of patient privacy)）。

When InsWhen paired with the MiniMed 780G, the Instinct sensor provides real-time glucose readings, and the system automatically adjusts insulin doses every five minutes accordingly, helping diabetes patients reduce the time spent managing their condition and increase the time enjoying life.

The launch of the Instinct sensor expands Medtronic's sensor portfolio, offering users more choices alongside the recently self-developed Simplera Sync sensor and Guardian 4 sensor — all part of an evolving ecosystem designed to make diabetes care simpler and more personalized.